Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Westervelt

Showing results (341-350 of 359) with videos related to

Pageof 36
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022Elizabeth A Griffiths, Vivek Roy, Laura Alwan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Blood Advances|April 6, 2026
Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell TherapySigrun Einarsdottir, Teng Fei, Katina H Singh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyJeffrey Crawford, Pamela Sue Becker, James O Armitage, et al.
Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell TransplantationRobert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyPeter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022Peter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Atmospheric Chemistry and Physics|December 4, 2020
Evaluation of global simulations of aerosol particle and cloud condensation nuclei number, with implications for cloud droplet formationGeorge S Fanourgakis, Maria Kanakidou, Athanasios Nenes, et al.
Pageof 36

Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022Elizabeth A Griffiths, Vivek Roy, Laura Alwan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Blood Advances|April 6, 2026
Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell TherapySigrun Einarsdottir, Teng Fei, Katina H Singh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyJeffrey Crawford, Pamela Sue Becker, James O Armitage, et al.
Nature Genetics|December 14, 2011
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesTimothy A Graubert, Dong Shen, Li Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Acquired copy number alterations in adult acute myeloid leukemia genomesMatthew J Walter, Jacqueline E Payton, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell TransplantationRobert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyPeter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022Peter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Atmospheric Chemistry and Physics|December 4, 2020
Evaluation of global simulations of aerosol particle and cloud condensation nuclei number, with implications for cloud droplet formationGeorge S Fanourgakis, Maria Kanakidou, Athanasios Nenes, et al.
Pageof 36